HT
XERS icon

HAP Trading’s Xeris Biopharma Holdings XERS Stock Holding History

HAP Trading’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-32,700
Closed -$2K – 1923
2022
Q3 		$2K Sell
32,700
-1,100
-3% -$1.82K ﹤0.01% 1607
2022
Q2 		$6K Sell
33,800
-7,378
-18% -$15.6K ﹤0.01% 1596
2022
Q1 		$12K Sell
41,178
-66,824
-62% -$163K ﹤0.01% 1737
2021
Q4 		$34K Buy
108,002
+9,002
+9% +$19.4K ﹤0.01% 1631
2021
Q3 		$26K Buy
99,000
+3,900
+4% +$11.3K ﹤0.01% 1732
2021
Q2 		$50K Buy
+95,100
New +$363K ﹤0.01% 1478
2021
Q1 		– Sell
-90,800
Closed -$78K – 2587
2020
Q4 		$78K Buy
+90,800
New +$454K ﹤0.01% 1267

Other funds holding XERS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return